Medicines Gaps Study

计划入组 3,000 人 · 首次发布于 2022 年 4 月 18 日

Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial

计划入组 76 人 · 首次发布于 2019 年 3 月 12 日

Development of the Medicines Optimisation Assessment Tool

计划入组 1,552 人 · 首次发布于 2015 年 10 月 21 日

DPP

Glomerulonephritis(Everest Medicines)

Protac (TYK medicines)

Blueprint Medicines

United States

3D MEDICINES

Hong Kong, China

The Medicines Company

United States

EMA's CHMP Recommends Approval for Ten New Medicines

BeOne Medicines and Revolution Medicines Forge Multi-Part Collaboration to Advance RAS(ON) Inhibitors for RAS-Addicted Cancers

EMA's Advisory Group to Review Lecanemab for Alzheimer's Treatment